Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
PGWFF PGG Wrightson Ltd
CRNX Crinetics Pharmaceuticals Inc
NDAQ Nasdaq Inc
PML PIMCO Municipal Income Fund II
BBLN Babylon Holdings Ltd
NEPT Neptune Wellness Solutions Inc
AEO American Eagle Outfitters Inc
BNS Bank of Nova Scotia
BAC Bank of America Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company. The Company is focused on the development of pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X syndrome (FXS), autism spectrum disorder (ASD), 22q11.2 deletion syndrome (22q), and a heterogeneous group of rare epilepsies known as developmental and epileptic encephalopathies (DEE). Its lead product candidate, Zygel (ZYN002 CBD Gel) is a cannabidiol (CBD) gel for FXS, ASD in pediatric patients, 22q, and a heterogeneous group of rare epilepsies known as DEE. Its clinical program for Zygel includes clinical trials evaluating Zygel in the treatment of behavioral symptoms of FXS, ASD and 22q and the reduction of seizures and the treatment of associated symptoms in patients with DEE syndromes.

Closing Price
$3.54
Day's Change
0.13 (3.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.58
Day's Low
3.32
Volume
(Light)
Volume:
709,784

10-day average volume:
1,238,264
709,784
  • Prev Close
    3.41
  • Today's Open
    3.40
  • Day's Range
    3.32-3.58
  • Avg Vol (10-day)
    1.2M
  • Last (time)
    4:00p ET 12/08/21
  • Last (size)
    5
  • 52-Wk Range
    3.08 - 9.00
    LowHigh
  • (02/10/21 - 12/06/21)
    15.12%
  • 101.9%
  • Market Cap
    145.9M
  • Shares Outstanding
    41.2M
  • -1.04
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.3
  • 33.00
  • (% of float 11/15/21)
    5.96

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.